- Filed
- May 1, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 24, 2025 | 151.92M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $131.55M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $132.41M |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $2.01M |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $865K |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | $190.42M |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $202.71M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $87.81M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $98.05M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $320.63M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $336.89M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $256.49M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $283.75M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $510.85M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $539.38M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $47.92M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 145.79M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $1.51M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$38.35M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.33 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.33 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $19.6M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $30.25M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$47.51M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$48.76M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $18.05M |
| Revenue | Q1 2025 · Mar 31, 2024 | $41.87M |